BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 377609)

  • 1. Cancer and survival after cadaveric donor renal transplantation.
    Sheil AG; Mahoney JF; Horvath JS; Johnson JR; Tiller DJ; May J; Stewart JH
    Transplant Proc; 1979 Mar; 11(1):1052-4. PubMed ID: 377609
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA; Kemp E
    Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant tumors under immunosuppression, a new problem in transplant-recipients].
    Enderlin F; Guisan Y
    Helv Chir Acta; 1973 Dec; 40(5):773-6. PubMed ID: 4589045
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignancies associated with renal transplantation.
    Penn I
    Urology; 1977 Jul; 10(1 Suppl):57-63. PubMed ID: 329521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor incidence in human allograft recipients.
    Penn I
    Transplant Proc; 1979 Mar; 11(1):1047-51. PubMed ID: 377608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cancer after renal transplantation].
    Brulles A; Hernández J; Caralps A; Masramon J; Lloveras J; Andréu J
    Rev Clin Esp; 1978 Jul; 150(1-2):109-10. PubMed ID: 360319
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer after transplantation in Catalonia.
    Vilardell J; Oppenheimer F; Castelao AM; Puig JM; Cantarell MC; Solá R; Lauzurica R
    Transplant Proc; 1992 Feb; 24(1):124. PubMed ID: 1539205
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of immunosuppression in the pathogenesis of basal cell carcinoma.
    Moloney FJ; Comber H; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Apr; 154(4):790-1. PubMed ID: 16536838
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression and malignancy.
    Br Med J; 1972 Sep; 3(5829):713-4. PubMed ID: 4562175
    [No Abstract]   [Full Text] [Related]  

  • 10. Another look at immunologic surveillance.
    Schwartz RS
    N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
    [No Abstract]   [Full Text] [Related]  

  • 11. Kaposi sarcoma in kidney transplant recipients.
    Myers BD; Kessler E; Levi J; Pick A; Rosenfeld JB; Tikvah P
    Arch Intern Med; 1974 Feb; 133(2):307-11. PubMed ID: 4591269
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignancy and immunosuppression.
    Kinlen LJ
    Proc R Soc Med; 1972 Mar; 65(3):242. PubMed ID: 4563298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumors and kidney transplantation].
    Brünisholz M; Hodel K; Brunner FP; Harder F; Torhorst J; Thiel G
    Schweiz Med Wochenschr; 1984 Dec; 114(51):1915-24. PubMed ID: 6395328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer in immunosuppressed patients.
    Maize JC
    JAMA; 1977 Apr; 237(17):1857-8. PubMed ID: 321824
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer in renal allograft recipients in Australia and New Zealand.
    Sheil AG
    Transplant Proc; 1977 Mar; 9(1):1133-6. PubMed ID: 325740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression.
    Gruber SA; Skjei KL; Sothern RB; Robison L; Tzardis P; Moss A; Gillingham K; Canafax DM; Matas AJ; Dunn DL
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1104-5. PubMed ID: 1989160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unusual vascular pattern of a nodular lesion in the dermoscopic examination of a kidney transplant recipient].
    Feito-Rodríguez M; González-Beato MJ; Pizarro A
    Actas Dermosifiliogr; 2008 May; 99(4):307-8. PubMed ID: 18394409
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA.
    Sheil AG; Disney AP; Mathew TH; Amiss N; Excell L
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1111-2. PubMed ID: 1989161
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cancer after kidney transplantation and immunosuppression].
    Ivanovski N; Popov Z; Kolevski P; Cakalaroski K; Antova Z; Spasovski G; Vlckova-Laskovska M; Zografski G
    Ann Urol (Paris); 2000 Oct; 34(5):336-9. PubMed ID: 11144722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.